Life Sciences in Action

BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to legal issues life sciences companies face when dealing with the FDA.

BioUtah president & CEO Kelvyn Cullimore interviews RenalytixAI CEO James McCullough to discuss the growth and innovations of RenalytixAI, a diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs.

With a manufacturing facility in China, Utah-based ATL Technology was faced to deal with COVID months before the pandemic hit the United States. In this episode BioUtah’s president & CEO Kelvyn Cullimore interviews Brad Brown, CEO of ATL Technology discusses how their dealings with the pandemic in China helped them prepare for and deal with COVID-19’s impact on a life sciences company.